XML 73 R60.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Commitments and Contingencies - Schedule of Unfunded Contractual Commitments (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021
--- | --- | ---
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount | [1] | $ 658,970 | $ 286,752
Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount | [1] | 652,957 | 282,913
Investment Funds And Vehicles |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount | [1],[2] | 6,013 | 3,839
Phathom Pharmaceuticals, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 66,500 | 43,250
Vida Health | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 40,000 | 0
Skydio, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 37,500 | 37,500
Oak Street Health, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 44,250 | 0
HilleVax, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 36,000 | 0
Axsome Therapeutics, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 42,000 | 0
Automation Anywhere, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 29,400 | 0
Iveric Bio Gene Therapy LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 24,750 | 0
Aryaka Networks, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 20,000 | 0
Blue Sprig Pediatrics, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 10,000 | 30,000
Finch Therapeutics Group, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 20,000 | 0
G1 Therapeutics, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 19,375 | 19,375
Alladapt Immunotherapeutics Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 15,000 | 0
ATAI Life Sciences N.V. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 14,000 | 0
Syndax Pharmaceutics Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 30,000
Dronedeploy Incorporation | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 12,500 | 0
Carbon Health Technologies, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 11,625 | 11,625
Locus Robotics Corporation | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 18,281 | 0
R V Share Limited Liability Company | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 8,500 | 13,500
App Direct Incorporation | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 10,000 | 0
Nuvolo Technologies Corporation | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 10,200 | 0
Equality Health, LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 17,500
Elation Health, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 7,500 | 0
Gritstone Bio, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 7,500 | 0
Viridian Therapeutics Inc | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 8,000 | 0
Tarsus Pharmaceuticals, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 18,563 | 0
Dashlane, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 10,000 | 19,300
Ouster, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 7,000 | 0
Akero Therapeutics, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 5,000 | 0
Alamar Biosciences, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 5,000 | 0
Fulfil Solutions Inc [Member] | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 5,000 | 0
Brain Corporation | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 20,020 | 20,000
Ceros, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,707 | 3,845
Signal Media Limited | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 3,750 | 0
Demandbase, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 3,750 | 9,375
Riviera Partners LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 3,500 | 0
Yipit, LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 2,250 | 2,250
Khoros (p.k.a Lithium Technologies) | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,812 | 1,812
ThreatConnect, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,600 | 1,600
Dispatch Technologies, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,250 | 0
Logic Source | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,209 | 0
Ikon Science Limited | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,050 | 1,050
Omeda Holdings, LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 938 | 0
Alchemer LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 890 | 0
3GTMS, LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 725 | 1,583
Agilence, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 800 | 800
Constructor.io Corporation [Member] | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 625 | 0
Mobile Solutions Services | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 742 | 424
Enmark Systems, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 457 | 457
Zimperium, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 1,088 | 0
Cybermaxx Intermediate Holdings, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 471 | 471
ShadowDragon, LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 333
Gryphon Networks Corp. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 268 | 268
Cytracom Holdings LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 225 | 225
Annex Cloud | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 386 | 0
Thumbtack, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 40,000 | 0
Better Therapeutics, Inc. | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 4,000
Logicworks | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 2,000
Pineapple Energy LLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 120
E Pay Policy Holdings L L C | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 250
Bicycle Therapeutics PLC | Debt Investments |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount |  | 0 | 10,000
Forbion Growth Opportunities Fund I C V | Investment Funds And Vehicles |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount | [2] | 3,187 | 3,839
Forbion Growth Opportunities Fund I I C V | Investment Funds And Vehicles |  |  |
Loss Contingencies [Line Items] |  |  |
Investment Company, Financial Commitment to Investee, Future Amount | [2] | $ 2,826 | $ 0
[1] | For debt investments, amounts represent unfunded commitments, including undrawn revolving facilities, which are available at the request of the portfolio company. Amount excludes unfunded commitments which are unavailable due to the borrower having not met certain milestones. These amounts also exclude $203.2 million and $34.9 million of unfunded commitments as of September 30, 2022, and December 31, 2021, respectively, to portfolio companies related to loans assigned to or directly committed by the Adviser Funds as described in "Note -12 Related Party Transactions".
[2] | For investment funds and vehicles, the amount represents uncalled capital commitments in private equity funds.

X
- Definition Amount of financial support to be provided in future by investment company to investee. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 20 -Section 50 -Paragraph 16 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66023616&loc=SL35737436-115832 + Details
Name: | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_DebtInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_InvestmentFundsAndVehiclesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_PhathomPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_VidaHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_SkydioIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_OakStreetHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_HilleVaxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AxsomeTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AutomationAnyWhereIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_IvericBioGeneTherapyLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AryakaNetworksIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_BlueSprigPediatricsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_FinchTherapeuticsGroupIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_G1TherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AlladaptImmunotherapeuticsincMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AtaiLifeSciencesNVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_SyndaxPharmaceuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_DronedeployIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_CarbonHealthTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_LocusRoboticsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_RVShareLimitedLiabilityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AppDirectIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_NuvoloTechnologiesCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_EqualityHealthLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ElationHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_GritstoneBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ViridianTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_TarsusPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_DashlaneIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_OusterIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AkeroTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AlamarBiosciencesIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_FulfilSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_BrainCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_CerosIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_SignalMediaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_DemandbaseIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_RivieraPartnersLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_YipitLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_KhorosPKLithiumTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ThreatConnectIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_DispatchTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_LogicSourceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_IkonScienceLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_OmedaHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AlchemerLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ThreeGTMSLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AgilenceIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ConstructorIoCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_MobileSolutionsServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_EnmarkSystemsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ZimperiumIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_CybermaxxIntermediateHoldingsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ShadowDragonLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_GryphonNetworksCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_CytracomHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_AnnexCloudMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ThumbtackIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_BetterTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_LogicworksMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_PineappleEnergyLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_EPayPolicyHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_BicycleTherapeuticsPLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ForbionGrowthOpportunitiesFundICVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_ForbionGrowthOpportunitiesFundIICVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |